Hormonal replacement therapy does not affect self-estimated pain or experimental pain responses in post-menopausal women suffering from fibromyalgia: A double-blind, randomized, placebo-controlled trial

Rheumatology

Volumn 50, Issue 3, 2011, Pages 544-551

  Stening, Kent D ^a,b   Eriksson, Olle ^a   Henriksson, Karl G ^c   Brynhildsen, Jan ^a   Lindh Åstrand, Lotta ^a   Berg, Göran ^a   Hammar, Mats ^a   Amandusson, Åsa ^d   Blomqvist, Anders ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINNAEUS UNIVERSITY   (Sweden)

^c Linköping University ^*  (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cold pressor test; Hormonal levels; Oestrogen; Pain; Quantitative sensory testing; Substitution

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ESTRADIOL; ESTROGEN; PLACEBO;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PROTOCOL; COLD PRESSOR TEST; COLD TOLERANCE; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; FIBROMYALGIA; HORMONE SUBSTITUTION; HUMAN; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; POSTMENOPAUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE SENSORY TEST; RANDOMIZED CONTROLLED TRIAL; SELF CONCEPT; SENSORY SYSTEM EXAMINATION; SKIN IRRITATION; TEMPERATURE; TREATMENT DURATION; TREATMENT OUTCOME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; BREAST TENDERNESS; COLD EXPOSURE; DEPRESSION; DYSMENORRHEA; ESTROGEN DEFICIENCY; SELF EVALUATION; THERMAL EXPOSURE; VAGINA BLEEDING;

ADMINISTRATION, CUTANEOUS; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FIBROMYALGIA; HUMANS; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; POSTMENOPAUSE;

EID: 79952030751     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq348     Document Type: Article

References (50)

1. Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
2. Henriksson KG. Fibromyalgia-from syndrome to disease. Overview of pathogenetic mechanisms. J Rehabil Med 2003;41:89-94.
3. Jensen KB, Kosek E, Petzke F et al. Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain. Pain 2009;144:95-100.
4. Hurtig IM, Raak RI, Kendall SA, Gerdle B, Wahren LK. Quantitative sensory testing in fibromyalgia patients and in healthy subjects: identification of subgroups. Clin J Pain 2001;17:316-22.
5. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 2005;75:6-21.
6. Sarzi-Puttini P, Buskila D, Carrabba M, Doria A, Atzeni F. Treatment strategy in fibromyalgia syndrome: where are we now? Semin Arthritis Rheum 2008;37:353-65.
7. Nishishinya B, Urrutia G, Walitt B et al. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology 2008;47:1741-6.
8. Riley JL 3rd, Robinson ME, Wise EA, Myers CD, Fillingim RB. Sex differences in the perception of noxious experimental stimuli: a meta-analysis. Pain 1998;74: 181-7.
9. Stening K, Eriksson O, Wahren L, Berg G, Hammar M, Blomqvist A. Pain sensations to the cold pressor test in normally menstruating women: comparison with men and relation to menstrual phase and serum sex steroid levels. Am J Physiol Regul Integr Comp Physiol 2007;293: R1711-6.
10. Amandusson A, Hermanson O, Blomqvist A. Colocalization of oestrogen receptor immunoreactivity and preproenkephalin mRNA expression to neurons in the superficial laminae of the spinal and medullary dorsal horn of rats. Eur J Neurosci 1996;8:2440-5.
11. Amandusson A, Hallbeck M, Hallbeck AL, Hermanson O, Blomqvist A. Estrogen-induced alterations of spinal cord enkephalin gene expression. Pain 1999;83:243-8.
12. Medina VM, Dawson-Basoa ME, Gintzler AR. 17 beta-estradiol and progesterone positively modulate spinal cord dynorphin: relevance to the analgesia of pregnancy. Neuroendocrinology 1993;58:310-5.
13. Blomqvist A. Sex hormones and pain: a new role for brain aromatase? J Comp Neurol 2000;423:549-51.
14. Wiesenfeld-Hallin Z. Sex differences in pain perception. Gend Med 2005;2:137-45.
15. LeResche L, Mancl L, Sherman JJ, Gandara B, Dworkin SF. Changes in temporomandibular pain and other symptoms across the menstrual cycle. Pain 2003; 106:253-61.
16. Yunus MB. Gender differences in fibromyalgia and other related syndromes. J Gend Specif Med 2002;5:42-7.
17. Pamuk ON, Cakir N. The variation in chronic widespread pain and other symptoms in fibromyalgia patients. The effects of menses and menopause. Clin Exp Rheumatol 2005;23:778-82.
18. Waxman J, Zatzkis SM. Fibromyalgia and menopause. Examination of the relationship. Postgrad Med 1986;80: 165-7, 170-1.
19. Toussirot E, Wendling D. Fibromyalgia developed after administration of gonadotrophin-releasing hormone analogue. Clin Rheumatol 2001;20:150-2.
20. Kahn MF. Does hormone replacement therapy discontinuation cause musculoskeletal pain? Joint Bone Spine 2006;73:488-9.
21. Ockene JK, Barad DH, Cochrane BB et al. Symptom experience after discontinuing use of estrogen plus progestin. JAMA 2005;294:183-93.
22. Greendale GA, Reboussin BA, Hogan P et al. Symptom relief and side effects of postmenopausal hormones: results from the postmenopausal estrogen/progestin interventions trial. Obstet Gynecol 1998;92:982-8.
23. Hays J, Ockene JK, Brunner RL et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839-54.
24. Aloisi AM, Bachiocco V, Costantino A et al. Cross-sex hormone administration changes pain in transsexual women and men. Pain 2007;132(Suppl. 1):S60-7.
25. Clayton AH, West SG. Combination therapy in fibromyalgia. Curr Pharm Des 2006;12:11-6.
26. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002;288: 321-33.
27. Chong PS, Cros DP. Technology literature review: quantitative sensory testing. Muscle Nerve 2004;29: 734-47.
28. Yarnitsky D, Sprecher E, Zaslansky R, Hemli JA. Heat pain thresholds: normative data and repeatability. Pain 1995; 60:329-32.
29. Mease PJ, Clauw DJ, Arnold LM et al. Fibromyalgia syndrome. J Rheumatol 2005;32:2270-7.
30. Dunkl PR, Taylor AG, McConnell GG, Alfano AP, Conaway MR. Responsiveness of fibromyalgia clinical trial outcome measures. J Rheumatol 2000;27:2683-91.
31. Siao P, Cros DP. Quantitative sensory testing. Phys Med Rehabil Clin N Am 2003;14:261-86.
32. Petzke F, Khine A, Williams D, Groner K, Clauw DJ, Gracely RH. Dolorimetry performed at 3 paired tender points highly predicts overall tenderness. J Rheumatol 2001;28:2568-9.
33. Berglund B, Harju EL. Master scaling of perceived intensity of touch, cold and warmth. Eur J Pain 2003;7:323-34.
34. Geisser ME, Gracely RH, Giesecke T, Petzke FW, Williams DA, Clauw DJ. The association between experimental and clinical pain measures among persons with fibromyalgia and chronic fatigue syndrome. Eur J Pain 2007;11:202-7.
35. Dadabhoy D, Crofford LJ, Spaeth M, Russell IJ, Clauw DJ. Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther 2008;10:211.
36. Geisser ME, Casey KL, Brucksch CB, Ribbens CM, Appleton BB, Crofford LJ. Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing. Pain 2003;102:243-50.
37. Berglund B, Harju EL, Kosek E, Lindblom U. Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain 2002;96:177-87.
38. Edens JL, Gil KM. Experimental induction of pain: utility in the study of clinical pain. Behav Ther 1995;26:197-216.
39. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58: 529-34.
40. de Souza JB, Goffaux P, Julien N, Potvin S, Charest J, Marchand S. Fibromyalgia subgroups: profiling distinct subgroups using the fibromyalgia impact questionnaire. A preliminary study. Rheumatol Int 2009;29:509-15.
41. Eichling PS, Sahni J. Menopause related sleep disorders. J Clin Sleep Med 2005;1:291-300.
42. Scharf MB, Baumann M, Berkowitz DV. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol 2003;30: 1070-4.
43. Adams MM, Fink SE, Shah RA et al. Estrogen and aging affect the subcellular distribution of estrogen receptor-alpha in the hippocampus of female rats. J Neurosci 2002;22:3608-14.
44. Sadreddini S, Molaeefard M, Noshad H, Ardalan M, Asadi A. Efficacy of raloxifen in treatment of fibromyalgia in menopausal women. Eur J Intern Med 2008;19:350-5.
45. Nemitz N, Kurmann PT, Van Linthoudt D. [Intensification of a diffuse chronic pain syndrome by the introduction of an aromatase inhibitor]. Praxis 2008;97:137-41.
46. Friedman AJ, Juneau-Norcross M, Rein MS. Adverse effects of leuprolide acetate depot treatment. Fertil Steril 1993;59:448-50.
47. LeResche L, Saunders K, Von Korff MR, Barlow W, Dworkin SF. Use of exogenous hormones and risk of temporomandibular disorder pain. Pain 1997;69:153-60.
48. Jansson C, Johansson S, Lindh-Astrand L, Hoffmann M, Hammar M. The prevalence of symptoms possibly related to the climacteric in pre- and postmenopausal women in Linkoping, Sweden. Maturitas 2003;45:129-35.
49. Fillingim RB, Edwards RR. The association of hormone replacement therapy with experimental pain responses in postmenopausal women. Pain 2001;92:229-34.
50. Macfarlane TV, Blinkhorn A, Worthington HV, Davies RM, Macfarlane GJ. Sex hormonal factors and chronic widespread pain: a population study among women. Rheumatology 2002;41:454-7.